Showing results (211-220 of 225) with videos related to
Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2023
Exceptional stratospheric contribution to human fingerprints on atmospheric temperatureBenjamin D Santer, Stephen Po-Chedley, Lilong Zhao, et al.Nature|November 30, 2012
The mystery of recent stratospheric temperature trendsDavid W J Thompson, Dian J Seidel, William J Randel, et al.Proceedings of the National Academy of Sciences of the United States of America|March 16, 2021
On the effects of the ocean on atmospheric CFC-11 lifetimes and emissionsPeidong Wang, Jeffery R Scott, Susan Solomon, et al.Biochemical and Biophysical Research Communications|December 31, 1991
HIV-1 protease inhibitory activity of L-694,746, a novel metabolite of L-689,502R B Lingham, B H Arison, L F Colwell, et al.Journal of Medicinal Chemistry|May 15, 1992
HIV-1 protease inhibitors based on hydroxyethylene dipeptide isosteres: an investigation into the role of the P1' side chain on structure-activityS D Young, L S Payne, W J Thompson, et al.Journal of Medicinal Chemistry|April 15, 1994
The development of cyclic sulfolanes as novel and high-affinity P2 ligands for HIV-1 protease inhibitorsA K Ghosh, H Y Lee, W J Thompson, et al.Journal of Medicinal Chemistry|May 15, 1992
Synthesis and antiviral activity of a series of HIV-1 protease inhibitors with functionality tethered to the P1 or P1' phenyl substituents: X-ray crystal structure assisted designW J Thompson, P M Fitzgerald, M K Holloway, et al.Journal of Medicinal Chemistry|March 1, 1990
Structure and activity of hydrogenated derivatives of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801)T A Lyle, C A Magill, S F Britcher, et al.Journal of Medicinal Chemistry|February 1, 1990
Synthesis and pharmacological evaluation of a series of dibenzo[a,d]cycloalkenimines as N-methyl-D-aspartate antagonistsW J Thompson, P S Anderson, S F Britcher, et al.Journal of Medicinal Chemistry|August 6, 1993
Potent HIV protease inhibitors: the development of tetrahydrofuranylglycines as novel P2-ligands and pyrazine amides as P3-ligandsA K Ghosh, W J Thompson, M K Holloway, et al.Pageof 23